Dr. Lal PathLabs Limited
LALPATHLAB
Rang in aandelen
#4527
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Aandeelprijs
$20.35
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$3.40B
Verandering (1 dag)
-0.86%
Verandering (1 jaar)
13.63%
Land
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Categorie
Healthcare
Aandelsplitsingen voor Dr. Lal PathLabs Limited (LALPATHLAB)
Het aandeel Dr. Lal PathLabs Limited (symbool: LALPATHLAB) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Dec 19, 2025.
Eén aandeel LALPATHLAB dat vóór Dec 19, 2025 werd gekocht, staat nu gelijk aan 2 aandelen LALPATHLAB.
De meest recente splitsing vond plaats op Dec 19, 2025.
Eén aandeel LALPATHLAB dat vóór Dec 19, 2025 werd gekocht, staat nu gelijk aan 2 aandelen LALPATHLAB.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2025-12-19 | 2:1 | x2 | x2 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
